# Evelo Biosciences Inc. (EVLO)

Source: https://www.quantisnow.com/company/EVLO
Generated: 2026-11-09T01:03:22.340Z

- Ticker: EVLO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: evelobio.com

## About

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

## Latest EVLO news and filings

- 2024-07-17 12:00 UTC [Leadership Update] [Alltrna Announces Updates to Its Board of Directors](https://www.quantisnow.com/insight/alltrna-announces-updates-to-its-board-of-directors-5611996)
- 2024-03-11 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-evelo-biosciences-inc-5332075)
- 2024-01-26 22:30 UTC [SEC Form 15-12G filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-evelo-biosciences-inc-5211870)
- 2024-01-26 22:29 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evelo-biosciences-inc-5211865)
- 2024-01-26 22:28 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-evelo-biosciences-inc-5211859)
- 2024-01-26 22:26 UTC [SEC Form 8-K] [Evelo Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/evelo-biosciences-inc-filed-sec-form-8-k-submission-of-matters-5211841)
- 2024-01-26 22:27 UTC [SEC Form POS AM filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-evelo-biosciences-inc-5211840)
- 2023-12-27 14:02 UTC [SEC Form 25-NSE filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-evelo-biosciences-inc-5155719)
- 2023-12-12 12:43 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-evelo-biosciences-inc-5131681)
- 2023-12-12 12:42 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-evelo-biosciences-inc-5131679)
- 2023-12-11 14:09 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Evelo Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-evelo-biosciences-inc-amendment-5129390)
- 2023-12-06 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-5121444)
- 2023-12-04 11:18 UTC [Market Chatter] [On December 1, 2023, Evelo Biosciences Was Notified By NASDAQ's Listing Qualifications That As A Result Of The Events Disclosed In Its Filing On November 21, The Staff Believes That The Company No Longer Has An Operating Business And Is Public Shell-8K](https://www.quantisnow.com/insight/on-december-1-2023-evelo-biosciences-was-notified-by-nasdaqs-5114963)
- 2023-12-04 11:04 UTC [SEC Form 8-K] [Evelo Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/evelo-biosciences-inc-filed-sec-form-8-k-notice-of-delisting-5114921)
- 2023-12-01 12:11 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-evelo-biosciences-inc-5112561)
- 2023-11-24 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-5102595)
- 2023-11-24 14:42 UTC [Market Insight] [US Stocks Mixed; Dow Gains 50 Points](https://www.quantisnow.com/insight/us-stocks-mixed-dow-gains-50-points-5102439)
- 2023-11-21 12:00 UTC [Market Chatter] [Regarding The Dissolution, Evelo Biosciences' Simba Gill Ceased Serving As The Company's President, CEO And President, And Marella Thorell Ceased Serving As The CFO, Secretary, Treasurer, Principal Financial Officer, And Principal Accounting Officer](https://www.quantisnow.com/insight/regarding-the-dissolution-evelo-biosciences-simba-gill-ceased-serving-as-5097421)
- 2023-11-21 11:44 UTC [SEC Form 8-K] [Evelo Biosciences Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evelo-biosciences-inc-filed-sec-form-8-k-leadership-update-other-5097332)
- 2023-11-17 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-5092619)
- 2023-11-15 19:04 UTC [Market Insight] [Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-shapeways-holdings-shares-are-trading-lower-by-around-20-5087265)
- 2023-11-15 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-5087061)
- 2023-11-13 14:02 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Evelo Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-evelo-biosciences-inc-amendment-5079373)
- 2023-11-09 22:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Evelo Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-evelo-biosciences-inc-5076189)
- 2023-11-09 01:32 UTC [SEC Form 4] [Bodmer Mark converted options into 6,625 shares and sold $1,044 worth of shares (3,163 units at $0.33), increasing direct ownership by 16% to 25,732 units (SEC Form 4)](https://www.quantisnow.com/insight/bodmer-mark-converted-options-into-6625-shares-and-sold-1044-5071914)
- 2023-11-09 01:32 UTC [SEC Form 4] [Mchale Duncan converted options into 6,500 shares and sold $1,024 worth of shares (3,103 units at $0.33), increasing direct ownership by 25% to 16,984 units (SEC Form 4)](https://www.quantisnow.com/insight/mchale-duncan-converted-options-into-6500-shares-and-sold-1024-5071913)
- 2023-11-09 01:31 UTC [SEC Form 4] [Gill Simba sold $57 worth of shares (172 units at $0.33) and converted options into 1,172 shares, increasing direct ownership by 6% to 17,758 units (SEC Form 4)](https://www.quantisnow.com/insight/gill-simba-sold-57-worth-of-shares-172-units-at-5071912)
- 2023-11-09 01:31 UTC [SEC Form 4] [Thorell Marella converted options into 6,500 shares and sold $598 worth of shares (1,811 units at $0.33), increasing direct ownership by 27% to 22,259 units (SEC Form 4)](https://www.quantisnow.com/insight/thorell-marella-converted-options-into-6500-shares-and-sold-598-5071910)
- 2023-11-06 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-5061554)
- 2023-11-03 20:12 UTC [SEC Form 4] [Bodmer Mark sold $2,262 worth of shares (6,854 units at $0.33) and converted options into 12,500 shares, increasing direct ownership by 34% to 22,270 units (SEC Form 4)](https://www.quantisnow.com/insight/bodmer-mark-sold-2262-worth-of-shares-6854-units-at-5059103)
- 2023-11-03 20:11 UTC [SEC Form 4] [Mchale Duncan converted options into 12,500 shares and sold $2,262 worth of shares (6,854 units at $0.33), increasing direct ownership by 71% to 13,587 units (SEC Form 4)](https://www.quantisnow.com/insight/mchale-duncan-converted-options-into-12500-shares-and-sold-2262-5059095)
- 2023-11-03 20:11 UTC [SEC Form 4] [Thorell Marella converted options into 12,500 shares and sold $1,320 worth of shares (3,999 units at $0.33), increasing direct ownership by 94% to 17,570 units (SEC Form 4)](https://www.quantisnow.com/insight/thorell-marella-converted-options-into-12500-shares-and-sold-1320-5059084)
- 2023-11-03 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-5058466)
- 2023-11-03 12:28 UTC [Market Insight] [Top 5 Health Care Stocks That Are Preparing To Pump In November](https://www.quantisnow.com/insight/top-5-health-care-stocks-that-are-preparing-to-pump-5057562)
- 2023-10-27 21:24 UTC [SEC Form 8-K] [Evelo Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evelo-biosciences-inc-filed-sec-form-8-k-entry-into-a-5042327)
- 2023-10-20 12:15 UTC [Market Insight] [Top 4 Health Care Stocks That May Rocket Higher This Month](https://www.quantisnow.com/insight/top-4-health-care-stocks-that-may-rocket-higher-this-5029964)
- 2023-10-18 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-5027213)
- 2023-10-18 17:14 UTC [Market Chatter] [Evelo Biosciences shares are trading lower after TD Cowen downgraded the stock from Outperform to Market Perform.](https://www.quantisnow.com/insight/evelo-biosciences-shares-are-trading-lower-after-td-cowen-downgraded-5026358)
- 2023-10-18 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-october-18-2023-5026083)
- 2023-10-18 08:44 UTC [Market Chatter] [TD Cowen Downgrades Evelo Biosciences to Market Perform](https://www.quantisnow.com/insight/td-cowen-downgrades-evelo-biosciences-to-market-perform-5025114)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EVLO
- Earnings history: https://www.quantisnow.com/earnings/EVLO
- Dividend history: https://www.quantisnow.com/dividends/EVLO
- Insider transactions: https://www.quantisnow.com/insiders/EVLO
- Options chain: https://www.quantisnow.com/options/EVLO
- SEC 8-K filings only: https://www.quantisnow.com/company/EVLO/8-k
- RSS and alerts for EVLO: https://www.quantisnow.com/docs/rss-feeds.md